EUVIMEDEUVIMED entdecken
Open Access

Novel ADAR2 variants in children with seizures, intellectual disability, and motor delay have reduced RNA editing

Qiupei Du, Anna Cherian, Raymond J Louie, Giulia Barcia, Natasha L Rudy, Rima Nabbout, Eugénie Sarda, Maelle Charpié, Wesley G Patterson, Liam P Keegan iD, Mary A O'Connell iD

RNA · 2025

DOI: 10.1261/rna.080600.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RNA, 2025. Verfasst von Qiupei Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central European Institute for Technology, Masaryk University, Brno 62500, Czechia. Hauptthemen laut MEDLINE: Adenosine Deaminase, Intellectual Disability, Motor Disorders, RNA-Binding Proteins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ADARB1 gene encodes the adenosine deaminase acting on RNA 2 (ADAR2) RNA editing enzyme, which edits the GRIA2 transcript Q/R editing site with almost 100% efficiency in the nervous system. The edited GRIA2 R transcript encodes the GLUA2 R subunit isoform of tetrameric α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, which is essential to prevent seizures associated with aberrantly elevated AMPA receptor cation permeability. Rare biallelic variants in ADARB1 cause severe infant and childhood seizures and developmental delays in seven cases we previously described. Here, we report two new homozygous ADARB1 variants and study ADAR2 variant editing activities at the GRIA2 Q/R site and other editing sites in cell cultures. One new variant in the second double-stranded RNA binding domain (dsRBD II) retains up to 60% editing activity, whereas another, in the deaminase domain, eliminates RNA editing activity. Reduced GRIA2 Q/R site editing increases AMPA receptor permeability by upregulating the expression of the GLUA2 Q isoform and reducing overall GLUA2 subunit levels, resulting in AMPA receptors that lack GLUA2 and are calcium-permeable. Because failure to edit the GRIA2 Q/R site leads to failure of intron 11 splicing, we also examined the effects of ADAR2 variants on the splicing of a mouse Gria2 -based reporter and concluded that ADAR2 variants affect splicing only through their effects on RNA editing activity. To expand the number of variants in ADARB1 , some variants reported in ClinVar have also been analyzed by in silico methods to predict which are likely to be most deleterious and associated with seizures in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseIntellectual DisabilityMotor DisordersRNA-Binding ProteinsSeizuresChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleComputer SimulationGene Expression RegulationHEK293 CellsHeLa CellsPolymorphism, Single NucleotideProtein IsoformsReceptors, AMPARNA EditingRNA Splicing

Stichwörter der Autor:innen

ADAR2ADARB1RNA editingseizures

Substanzen

ADARB1 protein, humanAdenosine Deaminaseglutamate receptor ionotropic, AMPA 2Protein IsoformsReceptors, AMPARNA-Binding Proteins

Autor:innen und Institutionen

  • Central European Institute for Technology, Masaryk University, Brno 62500, Czechia.
  • National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno 62500, Czechia.
  • Greenwood Genetic Center, Greenwood, South Carolina 29646, USA.
  • Department of Genetics, Necker Enfants Malades University Hospital, AP-HP, Université Paris Cité, 75015 Paris, France.
  • Laboratory of Translational Research for Neurological Disorders, UMR 1163 Institut National de la Santé et de la Recherche Médicale (INSERM), Imagine Institute, 75015 Paris, France.
  • Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker Enfants Malades University Hospital, AP-HP, Université Paris Cité, 75015 Paris, France.

ORCID-Profile: Liam P Keegan, Mary A O'Connell

Zitieren

APA

Du, Q., Cherian, A., Louie, R. J., Barcia, G., Rudy, N. L., Nabbout, R., Sarda, E., Charpié, M., Patterson, W. G., Keegan, L. P., & O'Connell, M. A. (2025). Novel ADAR2 variants in children with seizures, intellectual disability, and motor delay have reduced RNA editing. RNA. https://doi.org/10.1261/rna.080600.125

Vancouver

Du Q, Cherian A, Louie RJ, Barcia G, Rudy NL, Nabbout R, et al. Novel ADAR2 variants in children with seizures, intellectual disability, and motor delay have reduced RNA editing. RNA. 2025. doi:10.1261/rna.080600.125

BibTeX
@article{Du2025,
  author = {Du, Qiupei and Cherian, Anna and Louie, Raymond J and Barcia, Giulia and Rudy, Natasha L and Nabbout, Rima and Sarda, Eugénie and Charpié, Maelle and Patterson, Wesley G and Keegan, Liam P and O'Connell, Mary A},
  title = {Novel ADAR2 variants in children with seizures, intellectual disability, and motor delay have reduced RNA editing},
  journal = {RNA},
  year = {2025},
  doi = {10.1261/rna.080600.125}
}
Kostenlos starten →